[HTML][HTML] Physiology of hyperuricemia and urate-lowering treatments

CL Benn, P Dua, R Gurrell, P Loudon, A Pike… - Frontiers in …, 2018 - frontiersin.org
Gout is the most common form of inflammatory arthritis and is a multifactorial disease
typically characterized by hyperuricemia and monosodium urate crystal deposition …

An update on the genetics of hyperuricaemia and gout

TJ Major, N Dalbeth, EA Stahl… - Nature Reviews …, 2018 - nature.com
A central aspect of the pathogenesis of gout is elevated urate concentrations, which lead to
the formation of monosodium urate crystals. The clinical features of gout result from an …

Update on colchicine, 2017

A Slobodnick, B Shah, S Krasnokutsky… - …, 2018 - academic.oup.com
Colchicine is an ancient medication that is currently approved for the treatment of gout and
FMF. However, colchicine has a wide range of anti-inflammatory activities, and studies …

[HTML][HTML] Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual …

M Doherty, W Jenkins, H Richardson, A Sarmanova… - The Lancet, 2018 - thelancet.com
Background In the UK, gout management is suboptimum, with only 40% of patients receiving
urate-lowering therapy, usually without titration to achieve a target serum urate …

Рациональное использование нестероидных противовоспалительных препаратов. Клинические рекомендации

АЕ Каратеев, ЕЛ Насонов… - Научно …, 2018 - rsp.mediar-press.net
Аннотация В 2015 г. экспертами, представляющими различные врачебные ассоциации
России, были разработаны клинические рекомендации «Рациональное применение …

Drug-induced kidney stones and crystalline nephropathy: pathophysiology, prevention and treatment

M Daudon, V Frochot, D Bazin, P Jungers - Drugs, 2018 - Springer
Abstract Drug-induced calculi represent 1–2% of all renal calculi. The drugs reported to
produce calculi may be divided into two groups. The first one includes poorly soluble drugs …

U‐shaped association between serum uric acid level and risk of mortality: a cohort study

SK Cho, Y Chang, I Kim, S Ryu - Arthritis & rheumatology, 2018 - Wiley Online Library
Objective In addition to the controversy regarding the association of hyperuricemia with
cardiovascular disease (CVD) mortality, few studies have examined the impact of a low uric …

Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk

C Borghi, A Tykarski, K Widecka, KJ Filipiak… - Cardiology …, 2018 - journals.viamedica.pl
The definition of hyperuricemia (HU) varies widely in different studies, which makes the
epidemiological reports somewhat inconsistent. HU remains the culprit of the pathogenesis …

Medication adherence among patients with gout: a systematic review and meta-analysis

LEJM Scheepers, M van Onna, CDA Stehouwer… - Seminars in arthritis and …, 2018 - Elsevier
Objective In the management of chronic gout, a large proportion of patients need long-term
management with urate lowering therapy (ULT). This study reviews medication adherence to …

[HTML][HTML] Serum uric acid predicts incident metabolic syndrome in the elderly in an analysis of the Brisighella Heart Study

AFG Cicero, F Fogacci, M Giovannini, E Grandi… - Scientific reports, 2018 - nature.com
Several epidemiological studies report a positive correlation between hyperuricemia and
metabolic syndrome (MetS) in adults, which hyperuricemic subjects seem to more easily …